By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Health Canada 

A.L. 0904A

Ottawa    K1A 0K9  Canada
Phone: 613-957-2991 Fax: 613-941-5366



Company News
ESSA Pharma Receives Health Canada Approval To Commence Clinical Development For EPI-506 11/5/2015 6:42:58 AM
Anika Therapeutics (ANIK) Announces Health Canada Approval Of CINGAL For The Treatment Of Pain Associated With Osteoarthritis Of The Knee 11/3/2015 11:07:08 AM
Cynosure (CYNO) Receives Health Canada Authorization To Market MonaLisa Touch For Genitourinary Syndrome Of Menopause 10/28/2015 12:44:53 PM
Baxalta (BXLT) Gains Health Canada Approval For OBIZUR To Treat Patients With Acquired Hemophilia A 10/15/2015 6:56:10 AM
Health Canada Initiates Review Of PTC Therapeutics (PTCT)' New Drug Submission For Translarna For The Treatment Of Duchenne Muscular Dystrophy 9/18/2015 8:13:03 AM
Information Update - Health Canada Proposes Revised Labelling Standard For Non-Prescription Acetaminophen Products 9/16/2015 6:20:54 AM
Health Canada Approves Amgen (AMGN)'s New Cholesterol-Lowering Medication Repatha (evolocumab) 9/15/2015 6:10:12 AM
BioMark Diagnostics Receives Clearance From Health Canada To Commence Clinical Trial With Patented Non-Invasive, Urine-Based Assay To Measure Response To Treatment For Lung Cancer 9/9/2015 12:59:22 PM
Sandoz Canada Release: Health Canada Approves New Indications For Promnitrope (Somatropin), Canada's First Subsequent Entry Biologic (Biosimilar) 9/3/2015 7:13:44 AM
Relmada Therapeutics Receives Health Canada Clearance To Commence Multiple Ascending Dose Study With Promising NMDA Receptor Antagonist 8/17/2015 6:28:11 AM